Global Markets for Chiral Technology -- Focus on Europe

NEW YORK, June 4, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Markets for Chiral Technology -- Focus on Europe http://www.reportlinker.com/p0870810/Global-Markets-for-Chiral-Technology----Focus-on-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics

INTRODUCTION

STUDY OBJECTIVES

This report explores present and future strategies within the chiral market, including the synthesis, separation and analysis of chiral products. The improvisation of the market, the setbacks and the needs of the market are discussed in this report. An overview of chirality, and the chiral products and technologies used in the past and currently are discussed in this report.

A detailed analysis of the structure of the chiral industry has been conducted. This includes chiral synthesis, chiral separation/resolution and chiral analysis. Revenues are broken down by global region from 2009 to 2011 and estimated for the five-year period from 2011 through 2016.

Applications for chiral products and technologies are also discussed in this report, with an emphasis on the usage in the pharmaceutical, biochemical and agrochemical industries. The report also covers significant patents and their allotment in each category.

REASONS FOR DOING THIS STUDY

This study was conducted to provide an update of new developments in the chiral technology market. The current study covers the global market for chiral products, with a specific focus on the U.S. markets, European markets and emerging markets. This study was conducted to provide a detailed market analysis of chiral-enabling products, including the factors influencing this market. New advancements and the need for enantiopure compounds have driven growth within this market. This study looks at most of the systems influenced by these factors.

Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each system/technology in light of the new technologies, growing competition and changing customer needs.

INTENDED AUDIENCE

This study contributes to the areas of market growth in therapeutic segments through chiral products and technologies from the point of view of manufacturers and users. The pharmaceutical and biopharmaceutical industries, agrochemical industries, physicians, hospitals and research institutes will find this study to be of interest.

SCOPE OF THE STUDY

The scope of this study encompasses the chiral markets with their usage in the pharmaceutical, biotechnical and agrochemical markets. BCC analyzes each market and its applications by its need for chiral products, their regulatory environment, technology involved, market projections and market share. Technological issues include the latest trends and developments.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical, chemical, pharmaceutical and biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of chiral products. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, consulted newsletters, company literature, product literature and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.

ABOUT THE AUTHOR

Shalini S. Dewan holds a master's degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC include Reagents for Chromatography; Spectroscopy, An Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets. The lead consultant for this project was Ms. Ruma Chakravarty, who holds a master's degree in biophysics. She has tremendous experience in market research, quality, process improvement, and lean and six sigma concepts.

TABLE OF CONTENTS

CHAPTER ONE: INTRODUCTION 1

STUDY OBJECTIVES 1

REASONS FOR DOING THIS STUDY 1

INTENDED AUDIENCE 2

SCOPE OF THE STUDY 2

METHODOLOGY 2

INFORMATION SOURCES 2

ABOUT THE AUTHOR 3

RELATED BCC RESEARCH REPORTS 3

BCC ONLINE SERVICES 4

DISCLAIMER 4

CHAPTER TWO: EXECUTIVE SUMMARY 5

EXECUTIVE SUMMARY 5

EXECUTIVE SUMMARY (CONTINUED) 6

SUMMARY TABLE GLOBAL CHIRAL TECHNOLOGY MARKET BY

SEGMENT, THROUGH 2016 ($ MILLIONS) 7

SUMMARY FIGURE GLOBAL CHIRAL TECHNOLOGY MARKET BY

SEGMENT, THROUGH 2016 ($ MILLIONS) 7

CHAPTER THREE: OVERVIEW 8

DEFINITIONS 8

GENERAL CHARACTERISTICS OF ISOMERS 9

TYPES OF ISOMERISM 9

FIGURE 1 TYPES OF ISOMERISM 9

STRUCTURAL ISOMERISM 10

Skeletal Isomerism 10

Positional Isomerism 10

Functional Isomerism 10

STEREOISOMERISM 11

Geometric Isomerism 11

FIGURE 2 EXAMPLE 1 OF GEOMETRIC ISOMERISM 11

FIGURE 3 EXAMPLE 2 OF GEOMETRIC ISOMERISM 12

FIGURE 4 EXAMPLE 3 OF GEOMETRIC ISOMERISM 12

Properties of Geometrical Isomers 12

TABLE 1 CIS- VS TRANS-ISOMERS 13

Optical Isomerism 13

Properties of Optical Isomers 14

CHAPTER FOUR: CHIRAL TECHNOLOGY 15

CHIRAL SYNTHESIS 15

METHODS OF CHIRAL SYNTHESIS 15

Chiral Pool Synthesis 15

Asymmetric Induction 16

Chiral Auxiliaries 17

TABLE 2 EVANS-TYPE AUXILIARIES 18

Asymmetric Catalysis 18

Chiral Catalyst 18

Metal Ligand Complexes Derived from Chiral

Ligands 19

Chiral Organocatalysts 20

Biocatalysts 20

Types of Asymmetric Catalytic Oxidation Reactions 21

PRODUCTS FOR CHIRAL SYNTHESIS 22

Chiral Intermediates 22

Chiral Amino Acids 23

Chiral Epoxides and Glycidols 24

Saturated Chiral Propionic Acids 24

TABLE 3 CHIRAL INTERMEDIATES FOR VARIOUS INHIBITORS 25

TABLE 4 CHIRAL INTERMEDIATES FOR PHARMACEUTICAL

PRODUCTS 25

TABLE 4 (CONTINUED) 26

TABLE 4 (CONTINUED) 27

Chiral Catalysts 27

Chiral Acid Catalysts 28

Biocatalysts or Enzymes 28

Chiral Auxiliaries 29

Chiral Reagents 29

CHIRAL SEPARATION OR RESOLUTION 30

RESOLUTION BY CRYSTALLIZATION 30

CHIRAL RESOLVING AGENTS 31

CHIRAL COLUMN CHROMATOGRAPHY 31

KINETIC RESOLUTION 32

TABLE 5 PRODUCTION OF COMPOUNDS BY ENZYMATIC

RESOLUTION 33

IMPORTANCE OF CHIRALITY 33

ADVANTAGES 33

Advantages (Continued) 34

ENANTIOPURE MEDICATION 35

TABLE 6 RACEMIC AND ENANTIOMER DRUGS 36

CHAPTER FIVE: REGULATORY ASPECTS 37

APPROVALS OF CHIRAL DRUGS 37

TABLE 7 FDA APPROVALS OF NEW AND GENERIC CHIRAL DRUGS,

2009 TO OCT 2011 37

TABLE 7 (CONTINUED) 38

TABLE 7 (CONTINUED) 39

TABLE 8 FDA ANDA (ABBREVIATED NEW DRUG

APPLICATION)/GENERICS APPROVALS FOR CHIRAL DRUGS,

2009 TO OCT 2011 39

TABLE 8 (CONTINUED) 40

TABLE 8 (CONTINUED) 41

TABLE 8 (CONTINUED) 42

TABLE 8 (CONTINUED) 43

TABLE 9 NEW DRUG APPLICATIONS FOR CHIRAL DRUGS 43

TABLE 10 SAFETY ALERTS, 2009 THROUGH OCT 2010 43

TABLE 10 (CONTINUED) 44

TABLE 11 RECALLED CHIRAL DRUGS, 2009 TO OCT 2011 44

TABLE 11 (CONTINUED) 45

REGULATORY DEVELOPMENTS OF CHIRAL PRODUCTS 45

CHAPTER SIX: MARKET LEADERS IN CHIRAL PRODUCTS 46

TABLE 12 LEADING MANUFACTURERS/SUPPLIERS OF CHIRAL

INTERMEDIATES 46

TABLE 12 (CONTINUED) 47

TABLE 12 (CONTINUED) 48

TABLE 12 (CONTINUED) 49

TABLE 12 (CONTINUED) 50

TABLE 12 (CONTINUED) 51

TABLE 12 (CONTINUED) 52

TABLE 13 LEADING MANUFACTURERS/SUPPLIERS OF CHIRAL

CHEMICAL CATALYSTS 52

TABLE 13 (CONTINUED) 53

TABLE 13 (CONTINUED) 54

TABLE 14 LEADING MANUFACTURERS/SUPPLIERS OF CHIRAL

BIOCATALYSTS 54

TABLE 14 (CONTINUED) 55

TABLE 15 LEADING MANUFACTURERS/SUPPLIERS OF CHIRAL

AUXILIARIES 55

TABLE 15 (CONTINUED) 56

TABLE 16 LEADING MANUFACTURERS/SUPPLIERS OF OTHER

SYNTHETIC MATERIAL 56

TABLE 16 (CONTINUED) 57

TABLE 17 LEADING MANUFACTURERS/SUPPLIERS OF CHIRAL

STATIONARY PHASES AND COLUMNS 57

TABLE 17 (CONTINUED) 58

TABLE 17 (CONTINUED) 59

TABLE 18 LEADING MANUFACTURERS/SUPPLIERS OF CHIRAL

SOLVENT EXTRACTION REAGENTS AND INSTRUMENTS 59

TABLE 19 LEADING MANUFACTURERS/SUPPLIERS OF CHIRAL

RESOLVING/DERIVATIZING AND CRYSTALLIZING AGENTS 60

TABLE 19 (CONTINUED) 61

TABLE 20 LEADING MANUFACTURERS/SUPPLIERS OF CHIRAL

ANALYTICAL INSTRUMENTS 61

TABLE 20 (CONTINUED) 62

TABLE 20 (CONTINUED) 63

TABLE 20 (CONTINUED) 64

CHAPTER SEVEN: NEW DEVELOPMENTS 65

TABLE 21 NEW DEVELOPMENTS IN CHIRAL SYNTHESIS,

SEPARATION AND ANALYSIS, 2011 65

TABLE 21 (CONTINUED) 66

TABLE 21 (CONTINUED) 67

TABLE 22 NEW DEVELOPMENTS IN CHIRAL SYNTHESIS,

SEPARATION AND ANALYSIS, 2010 68

TABLE 22 (CONTINUED) 69

TABLE 22 (CONTINUED) 70

TABLE 22 (CONTINUED) 71

TABLE 22 (CONTINUED) 72

TABLE 23 NEW DEVELOPMENTS IN CHIRAL SYNTHESIS,

SEPARATION AND ANALYSIS, 2009 72

TABLE 23 (CONTINUED) 73

TABLE 23 (CONTINUED) 74

TABLE 23 (CONTINUED) 75

TABLE 23 (CONTINUED) 76

TABLE 23 (CONTINUED) 77

CHAPTER EIGHT: GLOBAL MARKET ANALYSIS 78

CHIRAL SYNTHESIS MARKET 78

CHIRAL INTERMEDIATES 79

Market Overview 79

Market Revenues 80

TABLE 24 GLOBAL MARKET FOR CHIRAL INTERMEDIATES BY

REGION, THROUGH 2016 ($ MILLIONS) 81

FIGURE 5 GLOBAL MARKET FOR CHIRAL INTERMEDIATES BY

REGION, 2009-2016 ($ MILLIONS) 81

CHIRAL CHEMICAL CATALYSTS 82

Market Overview 82

Market Revenues 83

TABLE 25 GLOBAL MARKET FOR CHIRAL CHEMICAL CATALYSTS

BY REGION, THROUGH 2016 ($ MILLIONS) 84

FIGURE 6 GLOBAL MARKET FOR CHIRAL CHEMICAL CATALYSTS

BY REGION, 2009-2016 ($ MILLIONS) 84

CHIRAL BIOCATALYST 85

Market Overview 85

Market Overview (Continued) 86

Market Revenues 87

TABLE 26 GLOBAL MARKET FOR CHIRAL BIOCATALYSTS BY

REGION, THROUGH 2016 ($ MILLIONS) 87

FIGURE 7 GLOBAL MARKET FOR CHIRAL BIOCATALYSTS BY

REGION, 2009-2016 ($ MILLIONS) 88

CHIRAL AUXILIARIES 88

Market Overview 89

Market Revenues 89

TABLE 27 GLOBAL MARKET FOR CHIRAL AUXILIARIES BY

REGION, THROUGH 2016 ($ MILLIONS) 90

FIGURE 8 GLOBAL MARKET FOR CHIRAL AUXILIARIES BY

REGION, 2009-2016 ($ MILLIONS) 90

OTHER SYNTHETIC CHIRAL MATERIALS 91

Market Overview 92

Market Revenues 93

TABLE 28 GLOBAL MARKET FOR OTHER SYNTHETIC CHIRAL

MATERIALS BY REGION, THROUGH 2016 ($ MILLIONS) 93

FIGURE 9 GLOBAL MARKET FOR OTHER SYNTHETIC CHIRAL

MATERIALS BY REGION, 2009-2016 ($ MILLIONS) 94

MARKET SHARES OF CHIRAL SYNTHESIS MARKET 94

TABLE 29 GLOBAL CHIRAL SYNTHESIS MARKET SHARES BY

REGION, 2010 (%) 94

FIGURE 10 GLOBAL CHIRAL SYNTHESIS MARKET SHARES BY

REGION, 2010 (%) 95

CHIRAL SEPARATION MARKET 95

CRYSTALLIZING AGENTS 96

Market Overview 97

Market Revenues 98

TABLE 30 GLOBAL MARKET FOR CRYSTALLIZING AGENTS BY

REGION, THROUGH 2016 ($ MILLIONS) 99

FIGURE 11 GLOBAL MARKET FOR CRYSTALLIZING AGENTS BY

REGION, 2009-2016 ($ MILLIONS) 99

CHROMATOGRAPHY COLUMNS AND REAGENTS 100

Market Overview 100

Market Revenues 101

TABLE 31 GLOBAL MARKET FOR CHROMATOGRAPHY COLUMNS

AND REAGENTS BY REGION, THROUGH 2016 ($ MILLIONS) 102

FIGURE 12 GLOBAL MARKET FOR CHROMATOGRAPHY COLUMNS

AND REAGENTS BY REGION, 2009-2016 ($ MILLIONS) 102

SOLVENT EXTRACTION REAGENTS AND INSTRUMENTS 102

Market Overview 103

Market Revenues 104

TABLE 32 GLOBAL MARKET FOR SOLVENT EXTRACTION

INSTRUMENTS AND REAGENTS BY REGION, THROUGH 2016 ($

MILLIONS) 104

FIGURE 13 GLOBAL MARKET FOR SOLVENT EXTRACTION

INSTRUMENTS AND REAGENTS BY REGION, 2009-2016 ($

MILLIONS) 105

ENZYMES IN KINETIC RESOLUTION 105

Market Overview 106

Market Overview (Continued) 107

Market Revenues 107

TABLE 33 GLOBAL MARKET FOR ENZYMES USED IN KINETIC

RESOLUTION BY REGION, THROUGH 2016 ($ MILLIONS) 108

FIGURE 14 GLOBAL MARKET FOR ENZYMES USED IN KINETIC

RESOLUTION BY REGION, 2009-2016 ($ MILLIONS) 108

MARKET SHARES OF CHIRAL SEPARATION MARKET 109

TABLE 34 GLOBAL CHIRAL SEPARATION MARKET SHARES BY

REGION, 2010 (%) 109

FIGURE 15 GLOBAL CHIRAL SEPARATION MARKET SHARES BY

REGION, 2010 (%) 109

CHIRAL ANALYSIS MARKET 110

CHIRAL LIQUID CHROMATOGRAPHY 110

Market Overview 111

Market Revenues 112

TABLE 35 GLOBAL MARKET FOR CHIRAL LIQUID

CHROMATOGRAPHY, THROUGH 2016 ($ MILLIONS) 112

FIGURE 16 GLOBAL MARKET FOR CHIRAL LIQUID

CHROMATOGRAPHY, 2009-2016 ($ MILLIONS) 113

CHIRAL GAS CHROMATOGRAPHY 113

Market Overview 114

Market Revenues 115

TABLE 36 GLOBAL MARKET FOR CHIRAL GAS

CHROMATOGRAPHY, THROUGH 2016 ($ MILLIONS) 115

FIGURE 17 GLOBAL MARKET FOR CHIRAL GAS

CHROMATOGRAPHY, 2009-2016 ($ MILLIONS) 116

CHIRAL CAPILLARY ELECTROPHORESIS 116

Market Overview 117

Market Revenues 118

TABLE 37 GLOBAL MARKET FOR CHIRAL CAPILLARY

ELECTROPHORESIS, THROUGH 2016 ($ MILLIONS) 118

FIGURE 18 GLOBAL MARKET FOR CHIRAL CAPILLARY

ELECTROPHORESIS, 2009-2016 ($ MILLIONS) 119

CHIRAL SUPERCRITICAL FLUID CHROMATOGRAPHY 119

Market Overview 120

Market Revenues 120

TABLE 38 GLOBAL MARKET FOR CHIRAL SUPERCRITICAL FLUID

CHROMATOGRAPHY, THROUGH 2016 ($ MILLIONS) 121

FIGURE 19 GLOBAL MARKET FOR CHIRAL SUPERCRITICAL

CHROMATOGRAPHY, 2009-2016 ($ MILLIONS) 121

CHIRAL POLARIMETERS 122

Market Overview 122

Market Revenues 123

TABLE 39 GLOBAL MARKET FOR CHIRAL POLARIMETERS,

THROUGH 2016 ($ MILLIONS) 123

FIGURE 20 GLOBAL MARKET FOR CHIRAL POLARIMETERS, 2009-

2016 ($ MILLIONS) 124

NMR SHIFT REAGENTS 124

Market Overview 125

Market Revenues 126

TABLE 40 GLOBAL MARKET FOR NMR SHIFT REAGENTS,

THROUGH 2016 ($ MILLIONS) 126

FIGURE 21 GLOBAL MARKET FOR NMR SHIFT REAGENTS, 2009-

2016 ($ MILLIONS) 127

OTHERS 127

Market Overview 128

Market Revenues 128

TABLE 41 GLOBAL MARKET FOR OTHER CHIRAL ANALYSIS

TECHNIQUES, THROUGH 2016 ($ MILLIONS) 129

FIGURE 22 GLOBAL MARKET FOR OTHER CHIRAL ANALYSIS

TECHNIQUES, 2009-2016 ($ MILLIONS) 129

MARKET SHARES OF THE CHIRAL ANALYSIS MARKET 129

TABLE 42 GLOBAL MARKET SHARES OF CHIRAL ANALYSIS

TECHNIQUES BY REGION, 2010 (%) 130

FIGURE 23 GLOBAL MARKET SHARES OF CHIRAL ANALYSIS

TECHNIQUES BY REGION, 2010 (%) 130

CHAPTER NINE: EUROPEAN MARKET ANALYSIS 131

EUROPEAN MARKET FOR CHIRAL TECHNOLOGIES 131

TABLE 43 EUROPEAN MARKET FOR CHIRAL TECHNOLOGIES BY

TECHNOLOGY TYPE, THROUGH 2016 ($ MILLIONS) 131

FIGURE 24 EUROPEAN MARKET FOR CHIRAL TECHNOLOGIES BY

TECHNOLOGY TYPE, 2009-2016 ($ MILLIONS) 132

CHIRAL SYNTHESIS MARKET 132

Market Revenues 133

TABLE 44 EUROPEAN MARKET FOR CHIRAL SYNTHESIS,

THROUGH 2016 ($ MILLIONS) 133

FIGURE 25 EUROPEAN MARKET FOR CHIRAL SYNTHESIS, 2009-

2016 ($ MILLIONS) 134

Chiral Intermediates 134

Market Overview 135

Market Revenue 136

TABLE 45 EUROPEAN MARKET FOR CHIRAL INTERMEDIATES,

THROUGH 2016 ($ MILLIONS) 136

FIGURE 26 EUROPEAN MARKET FOR CHIRAL INTERMEDIATES,

2009-2016 ($ MILLIONS) 136

Chiral Chemical Catalysts 137

Market Overview 137

Market Revenue 138

TABLE 46 EUROPEAN MARKET FOR CHIRAL CHEMICAL

CATALYSTS, THROUGH 2016 ($ MILLIONS) 138

FIGURE 27 EUROPEAN MARKET FOR CHIRAL CHEMICAL

CATALYSTS, 2009-2016 ($ MILLIONS) 139

Chiral Biocatalysts 139

Market Overview 139

Market Overview (Continued) 140

Market Revenue 141

TABLE 47 EUROPEAN MARKET FOR CHIRAL BIOCATALYSTS,

THROUGH 2016 ($ MILLIONS) 141

FIGURE 28 EUROPEAN MARKET FOR CHIRAL BIOCATALYSTS,

THROUGH 2016 ($ MILLIONS) 141

Chiral Auxiliaries 142

Market Overview 142

Market Revenue 143

TABLE 48 EUROPEAN MARKET FOR CHIRAL AUXILIARIES,

THROUGH 2016 ($ MILLIONS) 143

FIGURE 29 EUROPEAN MARKET FOR CHIRAL AUXILIARIES, 2009-

2016 ($ MILLIONS) 143

Other Synthetic Materials 144

Market Overview 144

Market Revenue 145

TABLE 49 EUROPEAN MARKET FOR OTHER SYNTHETIC

MATERIAL, THROUGH 2016 ($ MILLIONS) 145

FIGURE 30 EUROPEAN MARKET FOR OTHER SYNTHETIC

MATERIAL, 2009-2016 ($ MILLIONS) 145

CHIRAL SEPARATION MARKET 146

MARKET REVENUES 146

TABLE 50 EUROPEAN MARKET FOR CHIRAL SEPARATION BY

TYPE, THROUGH 2016 ($ MILLIONS) 147

FIGURE 31 EUROPEAN MARKET FOR CHIRAL SEPARATION BY

TYPE, 2009-2016 ($ MILLIONS) 147

CRYSTALLIZING AGENTS 148

Market Overview 148

Market Revenue 149

TABLE 51 EUROPEAN MARKET FOR CRYSTALLIZING AGENTS,

THROUGH 2016 ($ MILLIONS) 150

FIGURE 32 EUROPEAN MARKET FOR CRYSTALLIZING AGENTS,

2009-2016 ($ MILLIONS) 150

CHROMATOGRAPHY COLUMNS AND REAGENTS 150

Market Overview 151

TABLE 52 EUROPEAN MARKET FOR CHROMATOGRAPHY

COLUMNS AND REAGENTS, THROUGH 2016 ($ MILLIONS) 152

FIGURE 33 EUROPEAN MARKET FOR CHROMATOGRAPHY

COLUMNS AND REAGENTS, THROUGH 2016 ($ MILLIONS) 152

SOLVENT EXTRACTION REAGENTS AND INSTRUMENTS 152

Market Overview 153

Market Revenue 154

TABLE 53 EUROPEAN MARKET FOR SOLVENT EXTRACTION

INSTRUMENTS AND REAGENTS, THROUGH 2016 ($ MILLIONS) 154

FIGURE 34 EUROPEAN MARKET FOR SOLVENT EXTRACTION

INSTRUMENTS AND REAGENTS, 2009-2016 ($ MILLIONS) 155

ENZYMES IN KINETIC RESOLUTION 155

Market Overview 156

Market Revenue 157

TABLE 54 EUROPEAN MARKET FOR KINETIC RESOLUTION,

THROUGH 2016 ($ MILLIONS) 157

FIGURE 35 EUROPEAN MARKET FOR KINETIC RESOLUTION, 2009-

2016 ($ MILLIONS) 157

CHIRAL ANALYSIS MARKET 158

MARKET REVENUES 158

TABLE 55 EUROPEAN MARKET FOR CHIRAL ANALYSIS BY TYPE,

THROUGH 2016 ($ MILLIONS) 158

FIGURE 36 EUROPEAN MARKET FOR CHIRAL ANALYSIS, 2009 2016

($ MILLIONS) 159

CHIRAL LIQUID CHROMATOGRAPHY 159

Market Overview 160

Market Revenue 160

TABLE 56 EUROPEAN MARKET FOR LIQUID CHROMATOGRAPHY,

THROUGH 2016 ($ MILLIONS) 161

FIGURE 37 EUROPEAN MARKET FOR LIQUID CHROMATOGRAPHY,

2009-2016 ($ MILLIONS) 161

CHIRAL GAS CHROMATOGRAPHY 161

Market Overview 162

Market Revenue 163

TABLE 57 EUROPEAN MARKET FOR CHIRAL GAS

CHROMATOGRAPHY, THROUGH 2016 ($ MILLIONS) 163

FIGURE 38 EUROPEAN MARKET FOR CHIRAL GAS

CHROMATOGRAPHY, 2009-2016 ($ MILLIONS) 164

CHIRAL CAPILLARY ELECTROPHORESIS 164

Market Overview 165

Market Revenue 165

TABLE 58 EUROPEAN MARKET FOR CHIRAL CAPILLARY

ELECTROPHORESIS, THROUGH 2016 ($ MILLIONS) 166

FIGURE 39 EUROPEAN MARKET FOR CHIRAL CAPILLARY

ELECTROPHORESIS, 2009-2016 ($ MILLIONS) 166

CHIRAL SUPERCRITICAL FLUID CHROMATOGRAPHY 166

Market Overview 167

Market Revenue 167

TABLE 59 EUROPEAN MARKET FOR CHIRAL SUPERCRITICAL

FLUID CHROMATOGRAPHY, THROUGH 2016 ($ MILLIONS) 167

FIGURE 40 EUROPEAN MARKET FOR CHIRAL SUPERCRITICAL

FLUID CHROMATOGRAPHY, 2009-2016 ($ MILLIONS) 168

CHIRAL POLARIMETERS 168

Market Overview 168

Market Revenue 169

TABLE 60 EUROPEAN MARKET FOR CHIRAL POLARIMETERS,

THROUGH 2016 ($ MILLIONS) 169

FIGURE 41 EUROPEAN MARKET FOR CHIRAL POLARIMETERS,

2009-2016 ($ MILLIONS) 170

NMR SHIFT REAGENTS 170

TABLE 61 EXAMPLES OF CHIRAL NMR SHIFT REAGENTS 171

Market Overview 171

Market Revenue 171

TABLE 62 EUROPEAN MARKET FOR NMR SHIFT REAGENTS,

THROUGH 2016 ($ MILLIONS) 172

FIGURE 42 EUROPEAN MARKET FOR NMR SHIFT REAGENTS,

2009-2016 ($ MILLIONS) 172

OTHERS 172

Market Overview 173

Market Revenue 173

TABLE 63 EUROPEAN MARKET FOR OTHER CHIRAL ANALYSIS,

THROUGH 2016 ($ MILLIONS) 174

FIGURE 43 EUROPEAN MARKET FOR OTHER CHIRAL ANALYSIS,

THROUGH 2016 ($ MILLIONS) 174

INDUSTRY LEADER MARKET SHARES 174

CHIRAL INTERMEDIATES 174

TABLE 64 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL INTERMEDIATES IN EUROPE, 2010 (%) 175

FIGURE 44 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL INTERMEDIATES IN EUROPE, 2010 (%) 176

CHIRAL CHEMICAL CATALYSTS 176

TABLE 65 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL CHEMICAL CATALYSTS IN EUROPE, 2010 (%) 177

FIGURE 45 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL CHEMICAL CATALYSTS IN EUROPE, 2010 (%) 177

CHIRAL BIOCATALYSTS 178

TABLE 66 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL BIOCATALYSTS IN EUROPE, 2010 (%) 178

FIGURE 46 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL BIOCATALYSTS IN EUROPE, 2010 (%) 179

CHIRAL AUXILIARIES 179

TABLE 67 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL AUXILIARIES IN EUROPE, 2010 (%) 180

FIGURE 47 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL AUXILIARIES IN EUROPE, 2010 (%) 180

OTHER SYNTHETIC MATERIALS 181

TABLE 68 MANUFACTURER/SUPPLIER MARKET SHARES OF

OTHER SYNTHETIC MATERIALS IN EUROPE, 2010 (%) 181

FIGURE 48 MANUFACTURER/SUPPLIER MARKET SHARES OF

OTHER SYNTHETIC MATERIALS IN EUROPE, 2010 (%) 181

CHIRAL COLUMNS AND STATIONARY PHASES 182

TABLE 69 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL COLUMNS AND STATIONARY PHASES IN EUROPE, 2010

(%) 182

FIGURE 49 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL COLUMNS AND STATIONARY PHASES IN EUROPE, 2010

(%) 183

CHIRAL RESOLVING/CRYSTALLIZING AGENTS 183

TABLE 70 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL RESOLVING/CRYSTALLIZING AGENTS IN EUROPE,

2010 (%) 183

FIGURE 50 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL RESOLVING/CRYSTALLIZING AGENTS IN EUROPE,

2010 (%) 184

SOLVENT EXTRACTION REAGENTS AND INSTRUMENTS 184

TABLE 71 MANUFACTURER/SUPPLIER MARKET SHARES OF

SOLVENT EXTRACTION REAGENTS AND INSTRUMENTS IN

EUROPE, 2010 (%) 184

TABLE 71 (CONTINUED) 185

FIGURE 51 MANUFACTURER/SUPPLIER MARKET SHARES OF

SOLVENT EXTRACTION REAGENTS AND INSTRUMENTS IN

EUROPE, 2010 (%) 185

CHIRAL ANALYSIS INSTRUMENTS 186

TABLE 72 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL ANALYSIS INSTRUMENTS IN EUROPE, 2010 (%) 186

FIGURE 52 MANUFACTURER/SUPPLIER MARKET SHARES OF

CHIRAL ANALYSIS INSTRUMENTS IN EUROPE, 2010 (%) 187

CHAPTER TEN: MARKET BY INDUSTRY APPLICATION 188

INTRODUCTION 188

CHIRAL TECHNOLOGY MARKET BY INDUSTRY 188

TABLE 73 GLOBAL MARKET SHARES OF CHIRAL TECHNOLOGY

SALES BY INDUSTRY, 2010 (%) 189

FIGURE 53 GLOBAL MARKET SHARES OF CHIRAL TECHNOLOGY

SALES BY INDUSTRY, 2010 (%) 189

PHARMACEUTICALS 189

Pharmaceuticals (Continued) 190

TABLE 74 CHIRAL DRUGS FROM THERAPEUTIC CLASSES 191

TABLE 75 ENANTIOPURE DRUGS 191

TABLE 75 (CONTINUED) 192

TABLE 75 (CONTINUED) 193

Market Revenue 193

TABLE 76 GLOBAL SALES OF CHIRAL TECHNOLOGY ENABLING

PRODUCTS TO THE PHARMACEUTICAL INDUSTRY BY

PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 193

FIGURE 54 GLOBAL SALES OF CHIRAL TECHNOLOGY ENABLING

PRODUCTS TO THE PHARMACEUTICAL INDUSTRY BY

PRODUCT TYPE, 2009-2016 ($ MILLIONS) 194

Market Share 194

TABLE 77 GLOBAL MARKET SHARES OF CHIRAL TECHNOLOGY

ENABLING PRODUCTS USED BY THE PHARMACEUTICAL

INDUSTRY, 2010 (%) 195

FIGURE 55 GLOBAL MARKET SHARES OF CHIRAL TECHNOLOGY

IN THE PHARMACEUTICAL INDUSTRY BY PRODUCT TYPE, 2010

(%) 195

TABLE 78 U S SALES OF TOP 10 CHIRAL DRUGS, 2010 ($

MILLIONS) 196

BIOCHEMICALS 196

Amino Acids 197

Hydroxy Acids 197

Oligonucleotides 197

Peptides 198

Oligosaccharides 198

Vitamins 199

Market Revenues 199

TABLE 79 GLOBAL SALES OF CHIRAL TECHNOLOGY ENABLING

PRODUCTS TO THE BIOCHEMICAL INDUSTRY, THROUGH 2016

($ MILLIONS) 199

FIGURE 56 GLOBAL SALES OF CHIRAL TECHNOLOGY ENABLING

PRODUCTS TO THE BIOCHEMICAL INDUSTRY, 2009-2016 ($

MILLIONS) 200

Market Share 200

TABLE 80 GLOBAL MARKET SHARES OF CHIRAL TECHNOLOGY

ENABLING PRODUCTS USED IN THE BIOCHEMICAL INDUSTRY,

2010 (%) 201

FIGURE 57 GLOBAL MARKET SHARES OF CHIRAL TECHNOLOGY

ENABLING PRODUCTS USED IN THE BIOCHEMICAL INDUSTRY,

2010 (%) 201

PESTICIDES/AGROCHEMICAL INDUSTRY 201

Pesticides/Agrochemical … (Continued) 202

TABLE 81 CHIRAL PESTICIDES 203

Pesticides/Agrochemical … (Continued) 204

Market Revenues 205

TABLE 82 GLOBAL SALES OF CHIRAL TECHNOLOGY ENABLING

PRODUCTS IN THE AGROCHEMICAL INDUSTRY, THROUGH 2016

($ MILLIONS) 205

FIGURE 58 GLOBAL SALES OF CHIRAL TECHNOLOGY ENABLING

PRODUCTS IN AGROCHEMICAL INDUSTRY, THROUGH 2016 ($

MILLIONS) 206

Market Share 206

TABLE 83 GLOBAL MARKET SHARES OF CHIRAL TECHNOLOGY

ENABLING PRODUCTS USED IN THE AGROCHEMICAL

INDUSTRY, 2010 (%) 206

FIGURE 59 GLOBAL MARKET SHARES OF CHIRAL TECHNOLOGY

ENABLING PRODUCTS USED IN THE AGROCHEMICAL

INDUSTRY, 2010 (%) 207

OTHER INDUSTRIES 207

Aromas and Fragrances 207

Aromas and Fragrances (Continued) 208

TABLE 84 CHIRAL AROMA COMPOUNDS 209

Liquid Crystals 209

Liquid Crystals (Continued) 210

Polymers 211

Market Revenues 212

TABLE 85 GLOBAL SALES OF CHIRAL TECHNOLOGY ENABLING

PRODUCTS IN OTHER INDUSTRIES, THROUGH 2016 ($

MILLIONS) 212

FIGURE 60 GLOBAL SALES OF CHIRAL TECHNOLOGY ENABLING

PRODUCTS IN OTHER INDUSTRIES, THROUGH 2016 ($

MILLIONS) 213

Market Share 213

TABLE 86 GLOBAL MARKET SHARES OF CHIRAL TECHNOLOGY

ENABLING PRODUCTS USED IN OTHER INDUSTRIES, 2010 (%) 214

FIGURE 61 GLOBAL MARKET SHARES OF CHIRAL TECHNOLOGY

ENABLING PRODUCTS USED IN OTHER INDUSTRIES, 2010 (%) 214

CHAPTER ELEVEN: PATENT ANALYSIS 215

PATENTS BY YEAR 215

TABLE 87 U S PATENTS FOR CHIRAL PRODUCTS BY YEAR, 2009

TO OCT 2011 (NO ) 216

PATENTS BY TECHNOLOGY 216

TABLE 88 U S PATENTS FOR CHIRAL PRODUCTS BY

TECHNOLOGY, 2009 TO OCT 2011 (NO ) 217

FIGURE 62 U S PATENTS FOR CHIRAL PRODUCTS BY

TECHNOLOGY, 2009 TO OCT 2011 (NO ) 217

PATENTS BY TYPE 217

TABLE 89 U S PATENTS FOR CHIRAL SYNTHESIS BY TYPE, 2009

TO OCT 2011 (NO ) 218

FIGURE 63 U S PATENTS FOR CHIRAL SYNTHESIS BY TYPE, 2009

TO OCT 2011 (NO ) 218

TABLE 90 U S PATENTS FOR CHIRAL RESOLUTION BY TYPE, 2009

TO OCT 2011 (NO ) 219

FIGURE 64 U S PATENTS FOR CHIRAL RESOLUTION BY TYPE,

2009 TO OCT 2011 (NO ) 219

TABLE 91 U S PATENTS FOR CHIRAL ANALYSIS, 2009 TO OCT

2011 (NO ) 220

FIGURE 65 U S PATENTS BY TYPE FOR CHIRAL ANALYSIS, 2009

TO OCT 2011 (NO ) 220

PATENTS BY COMPANY 221

TABLE 92 U S PATENTS FOR CHIRAL SYNTHESIS BY COMPANY,

2009 TO OCT 2011 (NO ) 221

TABLE 92 (CONTINUED) 222

TABLE 93 U S PATENTS FOR CHIRAL RESOLUTION BY COMPANY,

2009 TO OCT 2011 (NO ) 223

TABLE 94 U S PATENTS FOR CHIRAL ANALYSIS BY COMPANY,

2009 TO OCT 2011 (NO ) 224

PATENTS BY COUNTRY 224

TABLE 95 U S PATENTS FOR CHIRAL SYNTHESIS BY COUNTRY,

2009 TO OCT 2011 (NO ) 224

TABLE 95 (CONTINUED) 225

TABLE 96 SHARES OF U S CHIRAL SYNTHESIS PATENTS BY

COUNTRY, 2009 TO OCT 2011 (%) 225

TABLE 96 (CONTINUED) 226

TABLE 97 U S PATENTS FOR CHIRAL RESOLUTION/SEPARATION

BY COUNTRY, 2009 TO OCT 2011 (NO ) 226

TABLE 98 SHARES OF U S CHIRAL RESOLUTION/SEPARATION

PATENTS BY COUNTRY, 2009 TO OCT 2011 (%) 227

TABLE 99 U S PATENTS FOR CHIRAL ANALYSIS BY COUNTRY,

2009 TO OCT 2011 (NO ) 227

TABLE 100 SHARES OF U S CHIRAL ANALYSIS PATENTS BY

COUNTRY, 2009 TO OCT 2011 (%) 228

PATENTS BY ASSIGNEE 228

TABLE 101 U S PATENTS FOR CHIRAL SYNTHESIS BY TYPE OF

ASSIGNEE/END USER, 2009 TO OCT 2011 (NO ) 228

TABLE 102 U S PATENTS FOR CHIRAL

RESOLUTION/SEPARATION BY TYPE OF ASSIGNEE/END USER,

2009 TO OCT 2011 (NO ) 229

TABLE 103 U S PATENTS FOR CHIRAL ANALYSIS BY TYPE OF

ASSIGNEE/END USER, 2009 TO OCT 2011 (NO ) 229

CHAPTER TWELVE: CURRENT CHIRAL MARKET ENVIRONMENT 230

INTRODUCTION 230

MARKET TRENDS IN THE ASYMMETRIC SYNTHESIS MARKET 231

MARKET TRENDS IN THE ASYMMETRIC SYNTHESIS MARKET 232

MARKET TRENDS IN CHIRAL RESOLUTION 233

MARKET TRENDS IN CHIRAL ANALYSIS 234

MARKET TRENDS IN CHIRAL … (CONTINUED) 235

MARKET TRENDS IN CHIRAL … (CONTINUED) 236

CHAPTER THIRTEEN: COMPANY PROFILES 237

3B SCIENTIFIC CORP 237

ABA CHEMICALS CORP 237

AESICA PHARMACEUTICALS LTD 238

AGILENT TECHNOLOGIES 238

ALLIED INDUSTRIAL CORP LTD 239

ALMAC GROUP LTD 239

AMPAC FINE CHEMICALS LLC 240

ARCH PHARMALABS LTD 240

ARRAN CHEMICAL CO LTD 241

AVANTIUM TECHNOLOGIES BV 242

AVANTOR PERFORMANCE MATERIALS 242

BACHEM AMERICAS 243

BASF SE 244

BAYER AG 244

BECKMAN COULTER INC 245

BIOCATALYSTS LTD 246

BOULDER SCIENTIFIC CO 246

BRUKER AXS GMBH 247

CAMBREX CORP 248

CARBOSYNTH LTD 249

CHEMTURA CORP 249

CHIRAL BIOSCIENCES LTD 250

CHIRAL MANAGEMENT 250

CHIRAL TECHNOLOGIES INC 251

CHIRAL TECHNOLOGIES EUROPE 251

CHIRALVISION BV 252

CHIROTECH TECHNOLOGY LTD 252

CHONGQING CHIRAL BIOCATALYSIS TECHNOLOGY CO LTD 253

CHROMACOL LTD 253

CHROMTECH GESELLSCHAFT FÜR ANALYTISCHE

MEßTECHNIK MBH 254

CODEXIS INC 254

CORDEN PHARMA SWITZERLAND LLC 255

CYTEC INDUSTRIES INC 256

DAICEL CORP 257

DAINIPPON SUMITOMO PHARMA CO LTD 257

DIONEX CORP 258

DOW CHEMICAL CO 259

DOW PHARMACEUTICAL SCIENCES 259

DSM PHARMACEUTICAL PRODUCTS 260

ENZYTECH CO LTD 261

EVOCATAL GMBH 261

FARBEN-CHEM EUROPE LTD 262

GENENCOR INTERNATIONAL INC 262

GILSON INC 263

JASCO INC 263

JOHNSON MATTHEY PLC 264

KANEKA CORP 265

KEMFINE LTD 266

KOCH MODULAR PROCESS SYSTEMS 266

LANXESS AG 267

LASERCHROM HPLC LABORATORIES LTD 268

LG CHEM EUROPE GMBH 268

LONZA 269

LOUSTON INTERNATIONAL INC 269

MACHEREY-NAGEL GMBH & CO KG 270

MARRESEARCH GMBH 270

MEGA S N C 271

MERCK KGAA 271

NOVASEP 272

NOVOZYMES A/S 273

OUTOTEC OYJ 273

PANALYTICAL INC 274

PDR-CHIRAL LLC 275

PERKINELMER 275

PHENOMENEX INC 276

PROZOMIX LTD 277

RARE EARTH PRODUCTS INC 277

REGIS TECHNOLOGIES INC 278

RHODIA INC USA 278

ROCHE APPLIED SCIENCE 279

ROUSSELET CENTRIFUGATION SA 280

RUDOLPH INSTRUMENTS 280

SHIMADZU CORP 281

SIGMA-ALDRICH 281

SILICYCLE 282

STREM CHEMICALS INC 283

SUPELCO INC 284

SYNQUEST LABORATORIES INC 284

SYNTHETECH INC 285

SYMRISE AG 285

TAKEDA PHARMACEUTICAL CO LTD 286

TCI AMERICA 287

TAKASAGO INTERNATIONAL CORP 288

THERMO FISHER SCIENTIFIC 288

VERENIUM CORP 289

WUXI APPTEC CO LTD 290

YAMAKAWA CHEMICAL 291

YMC AMERICA INC 291

ZHEJIANG CHIRAL MEDICINE CHEMICALS CO LTD 292

ZIRCHROM SEPARATIONS INC 292

APPENDIX: ABBREVIATIONS 293

ABBREVIATIONS 293

ABBREVIATIONS (CONTINUED) 294

ABBREVIATIONS (CONTINUED) 295

To order this report: Diagnostics Industry: Global Markets for Chiral Technology -- Focus on Europe

More Market Research Report

Check our Industry Analysis and Insights

__________________________
Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker